JACC-Heart Failure

Scope & Guideline

Enhancing Knowledge for Heart Health Professionals

Introduction

Explore the comprehensive scope of JACC-Heart Failure through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JACC-Heart Failure in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2213-1779
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2013 to 2024
AbbreviationJACC-HEART FAIL / JACC-Heart Fail.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The journal 'JACC: Heart Failure' focuses on the advancement of knowledge in the field of heart failure through rigorous research and clinical insights. It emphasizes the importance of guideline-directed medical therapy, innovative treatment strategies, and the management of comorbid conditions associated with heart failure.
  1. Heart Failure Management Strategies:
    The journal covers clinical trials and studies focusing on the management of heart failure, including pharmacological interventions, device therapy, and rehabilitation approaches.
  2. Epidemiology and Risk Factors:
    Research on the epidemiology of heart failure, including the identification of risk factors, comorbidities, and social determinants of health that influence patient outcomes.
  3. Innovative Therapies and Technologies:
    Exploration of new therapeutic strategies, including the use of sodium-glucose cotransporter inhibitors, novel devices, and digital health technologies for heart failure management.
  4. Patient-Centered Care:
    Emphasis on the importance of patient-reported outcomes, quality of life assessments, and the integration of patient preferences in heart failure treatment plans.
  5. Guideline-Directed Medical Therapy (GDMT):
    Studies focusing on the implementation, adherence, and optimization of GDMT in diverse populations, including challenges faced in clinical practice.
  6. Health Disparities in Heart Failure:
    Investigation into disparities in heart failure care and outcomes based on race, ethnicity, gender, and socioeconomic status.
Recent publications in 'JACC: Heart Failure' reveal several emerging themes that reflect the evolving landscape of heart failure research, focusing on innovative approaches, personalized medicine, and comprehensive care models.
  1. Digital Health and Telemedicine:
    A significant increase in studies exploring the use of digital health technologies, telemedicine, and remote patient monitoring for managing heart failure, especially post-COVID-19.
  2. SGLT2 Inhibitors and Heart Failure:
    Growing research interest in the application of SGLT2 inhibitors for heart failure management, highlighting their benefits beyond diabetes control and their impact on heart failure outcomes.
  3. Comorbid Conditions and Integrated Care:
    Emerging focus on the management of comorbidities alongside heart failure, particularly in relation to chronic kidney disease, obesity, and mental health, emphasizing a holistic approach to patient care.
  4. Health Equity and Social Determinants of Health:
    Increasing attention on health disparities and social determinants affecting heart failure outcomes, driving research that seeks to address inequities in access to care and treatment.
  5. Personalized Medicine Approaches:
    A trend towards personalized treatment strategies in heart failure, incorporating genetic, phenotypic, and biomarker data to tailor therapies to individual patient needs.

Declining or Waning

While 'JACC: Heart Failure' continues to thrive in many areas of research, certain themes are becoming less prominent in recent publications. These waning scopes reflect shifts in clinical focus and emerging evidence that may influence future research directions.
  1. Traditional Heart Failure Biomarkers:
    Research on conventional biomarkers like BNP and NT-proBNP is seeing a decline as newer, more comprehensive diagnostic approaches and biomarkers gain traction in heart failure management.
  2. Invasive Procedures for Diagnosis and Management:
    There is a noticeable decrease in studies centered on invasive procedures, such as routine cardiac biopsies or catheterizations, as non-invasive and remote monitoring technologies are increasingly preferred.
  3. Single-Factor Studies:
    Research focusing solely on single interventions or factors in heart failure is declining in favor of multi-faceted approaches that consider the complexity of patient care and the interaction of various treatment modalities.

Similar Journals

HEART & LUNG

Fostering Excellence in Critical Care and Cardiovascular Studies
Publisher: MOSBY-ELSEVIERISSN: 0147-9563Frequency: 6 issues/year

HEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.

Journal of the Saudi Heart Association

Championing Open Access to Cardiovascular Research
Publisher: DIGITAL COMMONS BEPRESSISSN: 1016-7315Frequency: 4 issues/year

The Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.

Cardiology Journal

Exploring the future of cardiac science.
Publisher: VIA MEDICAISSN: 1897-5593Frequency: 6 issues/year

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

AMERICAN JOURNAL OF CARDIOLOGY

Empowering Healthcare Professionals with Cutting-edge Insights
Publisher: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INCISSN: 0002-9149Frequency: 24 issues/year

The American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.

International Journal of Angiology

Bridging gaps in angiology through impactful research and dialogue.
Publisher: THIEME MEDICAL PUBL INCISSN: 1061-1711Frequency: 4 issues/year

Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.

Heart International

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: TOUCH MEDICAL MEDIA LTDISSN: 2036-2579Frequency: 2 issues/year

Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.

Cardiology Research and Practice

Connecting researchers and practitioners for impactful change.
Publisher: HINDAWI LTDISSN: 2090-8016Frequency: 1 issue/year

Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.

Journal of Cardiology

Advancing cardiovascular science for a healthier future.
Publisher: ELSEVIERISSN: 0914-5087Frequency: 12 issues/year

Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.

American Journal of Cardiovascular Drugs

Unveiling Breakthroughs in Cardiovascular Medicine
Publisher: ADIS INT LTDISSN: 1175-3277Frequency: 6 issues/year

American Journal of Cardiovascular Drugs, published by ADIS INT LTD, is a premier peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. With an ISSN of 1175-3277 and an E-ISSN of 1179-187X, this esteemed journal has established itself as a crucial platform for disseminating high-quality research since its inception in 2001. It holds a significant position in its domain, ranking in the second quartile (Q2) across several categories including Cardiology, Medicine (miscellaneous), and Pharmacology (medical) for the year 2023. With its Scopus ranks placing it in the 81st percentile for Cardiology and 77th percentile for Pharmacology, the journal is highly regarded among professionals, researchers, and students alike. While it is not an open-access journal, its comprehensive articles and systematic reviews provide an in-depth exploration of cardiovascular drug therapy, therapeutic advancements, and clinical practices, making it an invaluable resource for anyone invested in the future of cardiovascular health.

World Journal of Cardiology

Exploring the frontiers of cardiology and cardiovascular medicine.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1949-8462Frequency: 12 issues/year

World Journal of Cardiology, published by BAISHIDENG PUBLISHING GROUP INC, stands out as a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1949-8462, this journal serves a global audience, promoting knowledge dissemination and collaboration among researchers, healthcare professionals, and students dedicated to advancing cardiovascular health. The journal demonstrates its credibility and impact in the field by achieving a respectable Q2 ranking in the 2023 category of Cardiology and Cardiovascular Medicine. Notably, it is listed in the Scopus database, ranking #189 out of 387 journals, placing it in the 51st percentile, which underscores its relevance and contribution to contemporary cardiovascular research. Although it operates under a subscription model, the journal provides diverse access options, ensuring that critical findings reach a wide audience. Through its comprehensive scope and commitment to publishing high-quality articles, the World Journal of Cardiology plays a vital role in shaping the future of cardiovascular science, making it an invaluable asset for those involved in this essential discipline.